A Novel 3-Substituted Benzazepinone Growth Hormone Secretagogue (L-692,429)

Journal of Medicinal Chemistry

Volumn 37, Issue 7, 1994, Pages 897-906

  Schoen, William R ^a,b   Pisano, Judith M ^a,b   Prendergast, Kristine ^a,b   Wyvratt, Matthew J ^a,b   Fisher, Michael H ^a,b   Cheng, Kang ^a,b   Chan, Wanda W S ^a,b   Butler, Bridget ^a,b   Smith, Roy G ^a,b   Ball, Richard G ^a,b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Department of Basic Chemistry ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 3 METHYL N [2,3,4,5 TETRAHYDRO 2 OXO 1 [[2' (1H TETRAZOL 5 YL) 1,1' BIPHENYL 4 YL]METHYL] 1H 1 BENZAZEPIN 3 YL]BUTANAMIDE; 4' [[3 [(3 AMINO 3 METHYL 1 OXOBUTYL)AMINO] 2,3,4,5 TETRAHYDRO 2 OXO 1H 1 BENZAZEPIN 1 YL]METHYL] 1,1' BIPHENYL 2 CARBOXYLIC ACID; BENZAZEPINE DERIVATIVE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR DERIVATIVE; HEXAPEPTIDE; HUMAN GROWTH HORMONE; L 158077; L 158432; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG STRUCTURE; GROWTH HORMONE RELEASE; HYPOPHYSIS CELL; HYPOTHALAMUS FUNCTION DISORDER; ISOMER; MALE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0028294987     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00033a006     Document Type: Article

References (33)

1. Brown, P.; Preece, M. A.; Will, R. G. “Friendly fire” in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 1992, 340, 24-27.
2. Jorgensen, J. O. L.; Christiansen, J. S. Growth hormone therapy. Brave new senescence: GH in adults. Lancet 1993, 341, 1247-1248.
3. Lehrman, S. Challenge to growth hormone trial. Nature 1993, 364, 179.
4. Schoen, W. R.; Wyvratt, M. J., Jr.; Smith, R. G. Growth hormone secretagogues. In Annual Reports in Medicinal Chemistry; Bristol, J. A., Ed.; Academic Press: San Diego, CA, 1993; Vol. 28, Chapter 19.
5. Thomer, M. O. On the discovery of growth hormone-releasing hormone. Acta Psediatr. Suppl. 1993, 388, 2-7.
6. Low, L. C. K. Growth hormone-releasing hormone: clinical studies and therapeutic aspects. Neuroendocrinology 1991, 53 (Suppl. 1), 37-40.
7. Bowers, C. Y.; Chang, J.; Momany, F.; Folkers, K. In Molecular Endocrinology; MacIntyre, I., Ed.; Elsevier/North Holland: Amsterdam, 1977; p 287.
8. Bowers, C. Y. GH releasing peptides-structure and kinetics. J. Pediatr. Endocrinol. 1993, 6, 21-31.
9. Raynor, K.; Murphy, W. A.; Coy, D. H.; Taylor, J. E.; Moreau, J.-P.; Yasuda, K.; Bell, G. I.; Reisine, T. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Mol. Pharmacol. 1993, 43, 838-844.
10. Bell, G. I.; Reisine, T. Molecular biology of somatostatin receptors. Trends Neurosci. 1993, 16, 34-38.
11. Smith, R. G.; Cheng, K.; Schoen, W. R.; Pong, S. -S.; Hickey, G.; Jacks, T.; Butler, B.; Chan, W. W. -S.; Chaung, L.-Y. P.; Judith, F.; Taylor, J.; Wyvratt, M. J.; Fisher, M. H. A novel non-peptidyl growth hormone secretagogue. Science 1993, 260, 1640-1643.
12. Gertz, B. J.; Barrett, J. S.; Eisenhandler, R.; Krupa, D. A.; Wittreich, J. M.; Seibold, J. R.; Schneider, S. H. Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone releasing peptide. J. Clin. Endocrinol. Metab. 1993, 77, 1393-1397.
13. Watthey, J. W. H.; Stanton, J. L.; Desai, M.; Babiarz, J. E.; Finn, B. M. Synthesis and biological properties of (carboxyalkyl)aminosubstituted bicyclic lactam inhibitors of angiotensin converting enzyme. J. Med. Chem. 1985, 28, 1511-1516.
14. Graf, v. R. Umsetzungen mit N-carbonyl-sulfamidsSurechlorid, III. (Reactions of N-chlorosulfonyl isocyanate, III.) Chem. Ber. 1963, 96, 111-157.
15. Miyaura, N.; Yanagi, T.; Suzuki, A. The palladium-catalyzed crosscoupling reaction of phenylboronic acid with haloarenes in the presence of bases. Synth. Commun. 1981, 11, 513-519.
16. Shumann, R. F.; King, A. O.; Anderson, R. K. Ortho-lithiation process for the synthesis of 2-substituted l-(tetrazol-5-yl)benzenes. U.S. Pat. 5,039,814, 1991.
17. Davis, A. L.; Lloyd, R.; Fletcher, J.; Bayliss, L.; McCord, T. J. The syntheses and biological activities of o-aminophenylalanine and related compounds. Arch. Biochem. Biophys. 1963, 102, 48-51. Cheng, K. Unpublished results.
18. Carini, D. J.; Duncia, J. V.; Aldrich, P. E.; Chiu, A. T.; Johnson, A. L.; Pierce, M. E.; Price, W. A.; Santella, J. B.; Wells, G. J.; Wexler, R. R.; Wong, P. C.; Yoo, S.-E.; Timmermans, B. M. W. M. Nonpeptide angiotensin II receptor antagonists: The discovery of a series of lV-(biphenylmethyl)imidazoles as potent, orally active antihypertensives. J. Med. Chem. 1991, 34, 2525-2547.
19. Kubo, K.; Inada, Y.; Sugiura, Y.; Ojima, M.; Itoh, K.; Furukawa, Y.; Nishikawa, K.; Naka, T. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles. J. Med. Chem. 1993, 36, 1772-1784.
20. Cheng, K.; Chan, W. W. -S.; Butler, B.; Wei, L.; Schoen, W. R.; Wyvratt, M. J.; Fisher, M. H.; Smith, R. G. Stimulation of growth hormone release from rat primary pituitary cells by L-692,429, a novel non-peptidyl growth hormone secretagogue. Endocrinology 1993, 132, 2729-2731.
21. Momany, F. A.; Bowers, C. Y.; Reynolds, G. A.; Hong, A.; Newlander, K. Conformational energy studies and in vitro and in vivo activity data on growth hormone-releasing peptides. Endocrinology 1984, 114, 1531-1536.
22. Kearsley, S.; Smith, G. An alternative method for the alignment of molecular structures: Maximizing electrostatic and steric overlap. Tetrahedron Comput. Methodol. 1992, 3, 615-633.
23. QUANTA/CHARMm, Polygen Corp., 200 Fifth Avenue, Waltham, MA 02254. (1986, 1987, 1988, 1991).
24. Crippen, G. M.; Havel, T. F. Stable calculation of coordinates from distance information. Acta Crystallogr. 1978, A34, 282-284.
25. Bowers, C. Y.; Momany, F. A.; Reynolds, G. A.; Hong, A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 1984, 114, 1537-1545.
26. Cheng, K.; Chan, W. W. -S.; Barreto, A.; Convey, E. M.; Smith, R. G. The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3′,5′-monophosphate accumulation in rat primary pituitary cell culture. Endocrinology 1989, 124, 2791-2798.
27. Hickey, G.; Jacks, J.; Judith, F.; Taylor, J.; Schoen, W. R.; Krupa, D.; Cunningham, P.; Clark, J.; Smith, R. Efficacy and specificity of L-692,429, a novel nonpeptidyl growth hormone secretogogue in beagles. Endocrinology 1994,134, 695-701.
28. Ohto, S.; Shimabayashi, A.; Aono, M.; Okamoto, M. A general convenient one-pot procedure for the conversion of carboxylic acids into their t-butyl esters which is also applicable to aliphatic carboxylic acids. Synthesis 1982, 833-834.
29. Sheldrick, G. M. Phase annealing in SHELX-90; direct methods for larger structures. Acta Crystallogr. 1990, A46, 467-473.
30. Structure Determination Package Version 3. Enraf-Nonius, Delft. The Netherlands (1985). Implemented on a Sun Microsystems workstation.
31. Allinger, N.L.; Yuh, Y. H. MM2. QCPE 1981, 13, 395.
32. Rodbard, D.; Frazier, G. R. Statistical Analysis of Radioligand Assay Data. Methods Enzymol. 1975, 37, 3-22.
33. Bates, D.; Watts, D. Nonlinear Regression Analysis and its Applications; John Wiley and Sons: New York, 1988.